Anton Gueth - Net Worth and Insider Trading
Anton Gueth Net Worth
The estimated net worth of Anton Gueth is at least $3 Million dollars as of 2025-04-11. Anton Gueth is the Director of Antares Pharma Inc and owns about 467,577 shares of Antares Pharma Inc (ATRS) stock worth over $3 Million. Details can be seen in Anton Gueth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anton Gueth has not made any transactions after 2021-07-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Anton Gueth
Anton Gueth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anton Gueth owns 3 companies in total, including Antares Pharma Inc (ATRS) , Navidea Biopharmaceuticals Inc (NAVB) , and Spectrum Pharmaceuticals Inc (SPPI) .
Click here to see the complete history of Anton Gueth’s form 4 insider trades.
Insider Ownership Summary of Anton Gueth
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATRS | Antares Pharma Inc | 2022-05-24 | director |
NAVB | Navidea Biopharmaceuticals Inc | 2015-06-01 | director |
SPPI | Spectrum Pharmaceuticals Inc | 2012-03-27 | director |
Anton Gueth Latest Holdings Summary
Anton Gueth currently owns a total of 1 stock. Anton Gueth owns 467,577 shares of Antares Pharma Inc (ATRS) as of July 8, 2021, with a value of $3 Million.
Latest Holdings of Anton Gueth
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ATRS | Antares Pharma Inc | 2021-07-08 | 467,577 | 5.59 | 2,613,755 |
Holding Weightings of Anton Gueth
Anton Gueth Form 4 Trading Tracker
According to the SEC Form 4 filings, Anton Gueth has made a total of 1 transactions in Antares Pharma Inc (ATRS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Antares Pharma Inc is the sale of 100,000 shares on July 8, 2021, which brought Anton Gueth around $429,000.
Insider Trading History of Anton Gueth
- 1
Anton Gueth Trading Performance
GuruFocus tracks the stock performance after each of Anton Gueth's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anton Gueth is 37.02%. GuruFocus also compares Anton Gueth's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anton Gueth within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Anton Gueth's insider trading performs compared to the benchmark.
Performance of Anton Gueth
Anton Gueth Ownership Network
Ownership Network List of Anton Gueth
Ownership Network Relation of Anton Gueth

Anton Gueth Owned Company Details
What does Antares Pharma Inc do?
Who are the key executives at Antares Pharma Inc?
Anton Gueth is the director of Antares Pharma Inc. Other key executives at Antares Pharma Inc include See Remarks Peter C Richardson , Executive Vice President & CFO Fred M Powell , and See Remarks Peter J Graham .
Antares Pharma Inc (ATRS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Antares Pharma Inc Insider Transactions
Anton Gueth Mailing Address
Above is the net worth, insider trading, and ownership report for Anton Gueth. Currently GuruFocus does not have mailing address information for Anton Gueth.